CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 386 enrolled
Drug / intervention
Regional Anesthesia +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00431847
NCT00431847N/ACompleted
CompareCT.gov

Regional Anesthesia in Combat Trauma Improves Pain Disability Outcomes

VA Office of Research and Development·observational·Posted Feb 6, 2007·Updated May 15, 2017

In Brief

An observational study evaluating Regional Anesthesia and Standard Pain Management Protocol for Anxiety Disorders and 4 related conditions. Completed, enrolled 386 participants across 3 sites.

Detailed Summary

The purpose of this study is to examine the short and long-term benefits of implementing early regional anesthesia techniques for pain control after a major traumatic injury to one or more extremities during combat in the Iraqi/Afghanistan war, including the effects on acute and chronic pain, quality of life, and mental health.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety Disorders, Complex Regional Pain Syndrome Type II, Depressive Disorders, Post-Traumatic Stress Disorder, Substance Abuse
CountriesUnited States
CollaboratorsWalter Reed National Military Medical Center, Brooke Army Medical Center, University of Pennsylvania

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 6, 2007
Enrollment StartOct 1, 2007
Primary CompletionSep 1, 2013
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 19.4 years ago

Interventions

Regional Anesthesiaprocedure

Subject received regional anesthesia to affected limb(s) within 72 hours of traumatic event.

Standard Pain Management Protocolprocedure

Intermittent dosing of analgesics and anxiolytics instituted prior to continuous intravenously dosing which was individually titrated to patient care goals.